| Literature DB >> 28837390 |
Qi-Lin Zhang1, Qian-Hua Zhu2, Zheng-Qing Xie1, Bin Xu1, Xiu-Qiang Wang1, Jun-Yuan Chen1.
Abstract
Amphioxus is the closest living proxy for exploring the evolutionary origin of the immune system in vertebrates. To understand the immune responses of amphioxus to lipopolysaccharide (LPS), 5 ribosomal RNA (rRNA)-depleted libraries of amphioxus were constructed, including one control (0 h) library and 4 treatment libraries at 6, 12, 24, and 48 h post-injection (hpi) with LPS. The transcriptome of Branchiostoma belcheri was analyzed using strand-specific RNA sequencing technology (RNA-seq). A total of 6161, 6665, 7969, and 6447 differentially expressed genes (DEGs) were detected at 6, 12, 24, and 48 hpi, respectively, compared with expression levels at 0 h. We identified amphioxus genes active during the acute-phase response to LPS at different time points after stimulation. Moreover, to better visualize the resolution phase of the immune process during immune response, we identified 6057 and 5235 DEGs at 48 hpi by comparing with 6 and 24 hpi, respectively. Through real-time quantitative PCR (qRT-PCR) analysis of 12 selected DEGs, we demonstrated the accuracy of the RNA-seq data in this study. Functional enrichment analysis of DEGs demonstrated that most terms were related to defense and immune responses, disease and infection, cell apoptosis, and metabolism and catalysis. Subsequently, we identified 1330, 485, 670, 911, and 1624 time-specific genes (TSGs) at 0, 6, 12, 24, and 48 hpi. Time-specific terms at each of 5 time points were primarily involved in development, immune signaling, signal transduction, DNA repair and stability, and metabolism and catalysis, respectively. As this is the first study to report the transcriptome of an organism with primitive immunity following LPS challenge at multiple time points, it provides gene expression information for further research into the evolution of immunity in vertebrates.Entities:
Keywords: Branchiostoma belcheri; evolutionary immunity; immune response; lipopolysaccharide; strand-specific RNA-seq; transcriptome analysis
Mesh:
Substances:
Year: 2017 PMID: 28837390 PMCID: PMC5731807 DOI: 10.1080/15476286.2017.1367890
Source DB: PubMed Journal: RNA Biol ISSN: 1547-6286 Impact factor: 4.652
Figure 1.A. Summary of the number of up- and downregulated DEGs. B. Venn diagram of DEGs among four comparison groups (CGs). The number of common DEGs is indicated in black, the number of commonly up-and downregulated DEGs is indicated in orange and purple, respectively. C. Venn diagram of GO terms enriched among DEGs in the 4 CGs. D. Venn diagram of KEGG pathways enriched among DEGs in the 4 CGs. CG1, control vs. 6 hours post infection (hpi); CG2, control vs. 12 hpi; CG3, control vs. 24 hpi; CG4, control vs. 48 hpi.
Top 10 most upregulated and downregulated genes between 0 and 24 hours post-LPS injection.
| GeneID | log2Ratio(0h/24h) | Annotation | Gene name | FDR |
|---|---|---|---|---|
| The top 10 most upregulated genes | ||||
| 112430F | -18.22032425 | Tumor necrosis factor receptor superfamily member 16 | Ngfr | 2.76E-11 |
| 026750F | -16.0790908 | Fibronectin (Fragments) | Fn1 | 0.000192 |
| 248780F | -15.69322215 | Trypsin delta/gamma | DeltaTry | 0 |
| 203350F | -15.58255283 | Histone H2A.1 | H2A.1 | 0 |
| 002980R | -15.30114853 | Transmembrane matrix receptor MUP-4 | Mup-4 | 0 |
| 256850R | -14.8359887 | Histone H3-like centromeric protein CNA1 | CNA1 | 0 |
| 003260R | -14.4435152 | Zona pellucida sperm-binding protein 1 | Zp1 | 0 |
| 088970R | -14.22843715 | CDKN2AIP N-terminal-like protein | Cdkn2aipnl | 7.69E-07 |
| 018230F | -14.1855803 | Pancreatic secretory granule membrane major glycoprotein GP2 | Gp2 | 0 |
| 248630F | -13.92488095 | Histone H2B.6 | Th123 | 0 |
| The top 10 most downregulated genes | ||||
| 102380F | 9.337660986 | Transmembrane emp24 domain-containing protein 9 | Tmed9 | 2.05E-114 |
| 100790R | 9.521525178 | SCO-spondin | Sspo | 4.02E-64 |
| 230910R | 9.597579418 | Complement component C6 | C6 | 8.14E-67 |
| 098080R | 9.668176687 | Hypothetical protein | / | 2.02E-69 |
| 034440R | 9.860613824 | E3 ubiquitin-protein ligase TRIM32 | Trim32 | 5.24E-77 |
| 139330R | 9.895920693 | Dromaiocalcin-1 | Dcal1 | 0 |
| 112040R | 9.897505202 | 3-α-hydroxysteroid sulfotransferase | Std1 | 0 |
| 293820R | 10.05203989 | Kinesin light chain 3 | Klc3 | 2.45E-85 |
| 245710F | 10.43252017 | Hypothetical protein | / | 1.68E-104 |
| 133300R | 10.46494165 | Pro-Pol polyprotein | Pol | 0 |
The shared and specific pathways enriched by DEGs among all 4 comparison groups (CG1–4).
| Pathway | Pathway ID | FDR |
|---|---|---|
| The shared pathways across all CGs | ||
| NOD-like receptor signaling pathway | ko04621 | 2.04E-04 |
| The CG1-specific pathways | ||
| Focal adhesion | ko04510 | 3.60E-07 |
| Dilated cardiomyopathy | ko05414 | 1.75E-06 |
| ECM-receptor interaction | ko04512 | 1.18E-05 |
| Arrhythmogenic right ventricular cardiomyopathy (ARVC) | ko05412 | 9.58E-05 |
| Autoimmune thyroid disease | ko05320 | 4.46E-04 |
| Prion diseases | ko05020 | 7.59E-04 |
| RIG-I-like receptor signaling pathway | ko04622 | 1.05E-03 |
| Haematopoietic cell lineage | ko04640 | 2.18E-03 |
| Salmonella infection | ko05132 | 4.01E-03 |
| p53 signaling pathway | ko04115 | 4.01E-03 |
| Pancreatic secretion | ko04972 | 5.58E-03 |
| Tyrosine metabolism | ko00350 | 6.54E-03 |
| Melanoma | ko05218 | 1.01E-02 |
| Cardiac muscle contraction | ko04260 | 1.97E-02 |
| Regulation of actin cytoskeleton | ko04810 | 1.97E-02 |
| Drug metabolism – cytochrome P450 | ko00982 | 2.63E-02 |
| Bacterial invasion of epithelial cells | ko05100 | 2.71E-02 |
| Phototransduction – fly | ko04745 | 2.93E-02 |
| Bladder cancer | ko05219 | 3.25E-02 |
| Pathogenic Escherichia coli infection | ko05130 | 3.51E-02 |
| Toxoplasmosis | ko05145 | 3.86E-02 |
| Complement and coagulation cascades | ko04610 | 4.07E-02 |
| Carbohydrate digestion and absorption | ko04973 | 4.07E-02 |
| The CG2-specific pathways | ||
| Apoptosis | ko04210 | 1.61E-03 |
| Natural killer cell mediated cytotoxicity | ko04650 | 1.01E-02 |
| Endocytosis | ko04144 | 1.17E-02 |
| Antigen processing and presentation | ko04612 | 1.47E-02 |
| Thyroid cancer | ko05216 | 3.42E-02 |
| Colorectal cancer | ko05210 | 4.12E-02 |
| The CG3-specific pathways | ||
| DNA replication | ko03030 | 1.25E-08 |
| Cell cycle | ko04110 | 2.16E-08 |
| Nucleotide excision repair | ko03420 | 1.30E-02 |
| Metabolic pathways | ko01100 | 1.30E-02 |
| Progesterone-mediated oocyte maturation | ko04914 | 2.98E-02 |
| Glycosylphosphatidylinositol(GPI)-anchor biosynthesis | ko00563 | 2.98E-02 |
| Proteasome | ko03050 | 2.98E-02 |
| Mismatch repair | ko03430 | 3.64E-02 |
| Non-small cell lung cancer | ko05223 | 4.18E-02 |
| The CG4-specific pathways | ||
| Fat digestion and absorption | ko04975 | 2.86E-02 |
| Biosynthesis of unsaturated fatty acids | ko01040 | 3.15E-02 |
Figure 2.A. Time specificity of genes. Distribution of maximal tissue specificity scores calculated for each time-specific gene (τ > 0.85, TSGs) across all 5 time points. B. Summary of the number of TSGs at each time point.
Time-specific pathways enriched among TSGs at all 5 time points. TSGs, time-specific genes at each time point; hpi, hours post-injection.
| Pathway | Pathway ID | FDR |
|---|---|---|
| 0 h (control) | ||
| Vasopressin-regulated water reabsorption | ko04962 | 1.08E-09 |
| Progesterone-mediated oocyte maturation | ko04914 | 1.96E-03 |
| Phospholipase D signaling pathway | ko04072 | 2.93E-03 |
| 6 hpi | ||
| Prion diseases | ko05020 | 1.571E-10 |
| Dorso-ventral axis formation | ko04320 | 1.174E-06 |
| Notch signaling pathway | ko04330 | 1.266E-06 |
| Thyroid hormone signaling pathway | ko04919 | 3.719E-05 |
| T cell receptor signaling pathway | ko04660 | 0.0007369 |
| Fc gamma R-mediated phagocytosis | ko04666 | 0.0060352 |
| ECM-receptor interaction | ko04512 | 0.0464513 |
| 12 hpi | ||
| Complement and coagulation cascades | ko04610 | 1.25E-02 |
| 24 hpi | ||
| DNA replication | ko03030 | 2.105E-15 |
| Cell cycle | ko04110 | 5.712E-08 |
| Mismatch repair | ko03430 | 0.0004709 |
| Pyrimidine metabolism | ko00240 | 0.0011964 |
| Homologous recombination | ko03440 | 0.0032069 |
| Oocyte meiosis | ko04114 | 0.0057862 |
| Nucleotide excision repair | ko03420 | 0.0114305 |
| Systemic lupus erythematosus | ko05322 | 0.049154 |
| 48 hpi | ||
| Olfactory transduction | ko04740 | 0.0037022 |
| Glycosaminoglycan degradation | ko00531 | 0.004054 |
| Thyroid hormone synthesis | ko04918 | 0.0116272 |
Figure 3.Confirmation of the RNA-seq results via qRT-PCR of 12 randomly selected DEGs in the CG1 (A), CG2 (B), CG3 (C), and CG4 (D). Each point represents the fold-change in expression relative to 0 h (control), as measured by RNA-seq (x-axis) and qRT-PCR (y-axis).